Company intelligence / Profile preview

Zerion Pharma

Copenhagen, -, Denmarkzerion.eu ↗
Ownership
Private
Employees
~50
Development stage
Phase 1
01

Overview

Zerion Pharma develops proprietary formulations using its Dispersome® platform to improve the solubility, bioavailability, and patient convenience of poorly soluble oral drugs. The company partners with major pharma firms for both marketed products and new chemical entities. Its first cannabidiol formulation was set to enter clinical trials in 2024. In collaboration with Aché Laboratorios Farmacêuticos S.A., it aims to reformulate billion-dollar revenue drugs in oncology and neuroscience for improved patient outcomes.

Therapeutic areas
OncologyNeurologyOther
Modalities
Small molecules (focus on poorly soluble small molecule drugs)
Industry
Biotech
02

Drug pipeline

1 asset

ZN002

Discontinued
03

Partnerships

Aché Laboratorios Farmacêuticos S.A. (Brazil): Partnership for improved formulations in oncology & neuroscience; exclusive LATAM rights granted to Aché.Arla Foods Ingredients (long-term supply agreement for beta-lactoglobulin excipient)

Beyond the preview

Go deeper on Zerion Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zerion Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call